RAPID CORRECTION OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTCD) IN AN OTCD MOUSE MODEL USING A SELF-COMPLEMENTARY AAV2/8 VECTOR

被引：0
|
作者：
Jones, D. J. [1 ]
Wang, H. [2 ]
Bell, P. [2 ]
Avilan-Dorante, A. [2 ]
Gao, G. [3 ]
Batshaw, M. L. [4 ]
Wilson, J. M. [2 ]
Wang, L. [2 ]
Morizono, H. [1 ]
机构：
[1] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC 20010 USA
[2] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA
[3] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA
[4] Childrens Natl Med Ctr, Childrens Res Inst, Washington, DC 20010 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2009年 / 98卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
728
引用
收藏
页码：147 / 147
页数：1
相关论文
共 29 条
  • [1] Rapid Correction of Ornithine Transcarbamylase Deficiency (OTCD) in OTCD Mouse Model by Self-Complementary AAV2/8 Vector
    Wang, Huan
    Wang, Lili
    Morizono, Hiroki
    Jones, David
    Bell, Peter L.
    Dorante, A. Avilan
    Gao, Guangping
    Batshaw, Mark L.
    Wilson, James M.
    MOLECULAR THERAPY, 2009, 17 : S69 - S69
  • [2] OPTIMIZATION OF A SELF-COMPLEMENTARY AAV2/8 VECTOR FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    Jones, D.
    Wang, H.
    Bell, P.
    Dorante, A. Avilan
    Gao, G.
    Batshaw, M. L.
    Wilson, J. M.
    Wang, L.
    Morizono, H.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (03) : 226 - 227
  • [3] Sustained correction of OTC deficiency in spfash mice using optimized self-complementary AAV2/8 vectors
    Wang, L.
    Wang, H.
    Morizono, H.
    Bell, P.
    Jones, D.
    Lin, J.
    McMenamin, D.
    Yu, H.
    Batshaw, M. L.
    Wilson, J. M.
    GENE THERAPY, 2012, 19 (04) : 404 - 410
  • [4] Sustained correction of OTC deficiency in spfash mice using optimized self-complementary AAV2/8 vectors
    L Wang
    H Wang
    H Morizono
    P Bell
    D Jones
    J Lin
    D McMenamin
    H Yu
    M L Batshaw
    J M Wilson
    Gene Therapy, 2012, 19 : 404 - 410
  • [5] Liver Directed Gene Therapy Using Non-Viral Minicircle-DNA Vector for Ornithine Transcarbamylase Deficiency (OTCD)
    Viecelli, Hiu Man
    Schlegel, Andrea
    Deplazes, Sereina
    Cunningham, Sharon
    Alexander, Ian
    Haeberle, Johannes
    Thoeny, Beat
    MOLECULAR THERAPY, 2015, 23 : S60 - S60
  • [6] AAV retinal transduction in a large animal model species: Comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector
    Petersen-Jones, S. M.
    Bartoe, J. T.
    Fischer, A. J.
    Scott, M.
    Boye, S. L.
    Chiodo, V.
    Hauswirth, W. W.
    MOLECULAR VISION, 2009, 15 (194-95): : 1835 - 1842
  • [7] Functional correction and reversal of MPS IIIA in a mouse model by an intravenous hSGSH gene delivery using a self-complementary AAV9 vector
    McCarty, Douglas M.
    Zaraspe, Kimberly
    Murrey, Darren
    Ware, Tierra
    Fu, Haiyan
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S75 - S75
  • [8] AAV2/8-Mediated correction of OTC deficiency in the adult and neonatal spfash mouse
    Cunningham, S. C.
    Spinoulas, A.
    Dane, A. P.
    Carpenter, K.
    Wilcken, B.
    Kuchell, P.
    Alexander, I. E.
    JOURNAL OF GENE MEDICINE, 2007, 9 (06): : 527 - 528
  • [9] Efficient Protection of Retina By Tyrosine-Mutated Self-Complementary AAV2 Vector Encoding BDNF in a Rat Retinal Ischemic Injury Model
    Igarashi, Tsutomu
    Miyake, Koichi
    Kobayashi, Maika
    Takahashi, Kazuhisa
    Miyake, Noriko
    Iijima, Osamu
    Nakamoto, Kenji
    Hirai, Yukihiko
    Shimada, Takashi
    Takahashi, Hiroshi
    MOLECULAR THERAPY, 2014, 22 : S47 - S47
  • [10] A metabolically responsive insulin transgene delivered by AAV2/8 pseudotyped, self-complementary AAV (SC-AAV2/8) controls glycemia in STZ-diabetic mice
    Kozlowski, M
    Lyszcowizc, D
    Campbell, AG
    Olson, DE
    Rubin, JE
    Thule, PM
    MOLECULAR THERAPY, 2004, 9 : S143 - S144
123